Russell Investments Group Ltd. Has $4.06 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Russell Investments Group Ltd. trimmed its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,540 shares of the company's stock after selling 19,002 shares during the period. Russell Investments Group Ltd. owned approximately 0.29% of U.S. Physical Therapy worth $4,055,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Envestnet Asset Management Inc. boosted its stake in shares of U.S. Physical Therapy by 53.2% in the third quarter. Envestnet Asset Management Inc. now owns 163,956 shares of the company's stock worth $15,040,000 after acquiring an additional 56,957 shares during the last quarter. Bahl & Gaynor Inc. boosted its position in U.S. Physical Therapy by 95.5% during the fourth quarter. Bahl & Gaynor Inc. now owns 100,315 shares of the company's stock worth $9,343,000 after acquiring an additional 49,013 shares during the last quarter. Schroder Investment Management Group grew its stake in U.S. Physical Therapy by 12.1% during the 3rd quarter. Schroder Investment Management Group now owns 384,936 shares of the company's stock valued at $35,310,000 after acquiring an additional 41,414 shares in the last quarter. Northern Trust Corp lifted its stake in U.S. Physical Therapy by 9.5% in the 3rd quarter. Northern Trust Corp now owns 227,704 shares of the company's stock worth $20,887,000 after purchasing an additional 19,661 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in shares of U.S. Physical Therapy by 1.7% in the third quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company's stock valued at $95,051,000 after purchasing an additional 17,156 shares in the last quarter.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 1,800 shares of the firm's stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total transaction of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares of the company's stock, valued at approximately $2,272,834.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO Graham D. Reeve sold 2,629 shares of the company's stock in a transaction on Monday, March 4th. The stock was sold at an average price of $104.39, for a total transaction of $274,441.31. Following the completion of the sale, the chief operating officer now directly owns 6,902 shares in the company, valued at approximately $720,499.78. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Carey P. Hendrickson sold 1,800 shares of the business's stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares of the company's stock, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,829 shares of company stock valued at $1,141,535. Corporate insiders own 1.70% of the company's stock.

U.S. Physical Therapy Stock Performance

USPH traded up $1.36 during trading on Friday, reaching $106.39. The company's stock had a trading volume of 60,867 shares, compared to its average volume of 65,961. The company has a market capitalization of $1.60 billion, a price-to-earnings ratio of 86.50, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. The company's fifty day moving average price is $105.35 and its 200-day moving average price is $96.70. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $124.11. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.28 and a current ratio of 2.16.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.58 by ($0.07). The company had revenue of $155.70 million during the quarter, compared to analysts' expectations of $153.30 million. U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. The company's quarterly revenue was up 4.8% on a year-over-year basis. During the same period last year, the business posted $0.59 earnings per share. On average, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.9 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd will be given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 1.65%. The ex-dividend date is Wednesday, May 22nd. U.S. Physical Therapy's payout ratio is 143.09%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Monday, March 18th. Barrington Research reaffirmed an "outperform" rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday. Finally, JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an "overweight" rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $125.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.